Ocuspecto Oy
USPTO PatentsView assignee record - 7 granted patents across 3 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Ocuspecto ranks #36,781 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 3 technology areas.
- #36,781
- of 49,997 US assignees by volume
- 5th percentile
- by Innovation Score (18.8/100)
- 9.1
- avg claims per patent
- +150%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R36781 · Foreign Corporation #36,781 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 7 grants
- MID-PACK #36,781/49,997
- PHOTO-FINISH Observa
- CPC-NARROW A61B · 3 areas
- INNOV-LOW 18.8/100
- CLAIMS-PAR 9.1 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +150% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Observa, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Ocuspecto’s 18.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Ocuspecto
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Ocuspecto Oy · this assignee 19
Ocuspecto Oy · this assignee
19 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Ocuspecto's Innovation Score is 18.8/100 (5th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Ocuspecto?
Each dot is one of Ocuspecto’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ocuspecto’s own 9.1 claims/patent is ABOVE the 4.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Ocuspecto's grants concentrate
Ocuspecto Oy is a focused PatentsView assignee: 3 CPC subclasses with 85.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (4 grants) versus a trough of 1 in 2015. By volume, Ocuspecto sits between Oxti PTE Ltd and Offset Ventures, LLC.
Who files at Ocuspecto's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Oxti PTE
Oxti PTE Ltd
7 patents
- Observa
Observa, Inc.
7 patents
- Oceanstar Design…
Oceanstar Design Group, Inc.
7 patents
- Ocugen
Ocugen, Inc.
7 patents
- Odaseva SAS
Odaseva Technologies SAS
7 patents
- Office Depot
Office Depot, Inc.
7 patents
- Officina Gourmet
Officina Gourmet GmbH
7 patents
- Offset Ventures
Offset Ventures, LLC
7 patents
- Ocuspecto Oy ◀
Ocuspecto Oy
7 patents
What this shows Ocuspecto holds 7 patents at rank #36,808, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Ocuspecto
By rank, the assignees closest to #36,808 in granted patent volume.
- Oxti PTE Ltd #36,804 · 7 patents
- Observa, Inc. #36,805 · 7 patents
- Oceanstar Design Group, Inc. #36,806 · 7 patents
- Ocugen, Inc. #36,807 · 7 patents
- Odaseva Technologies SAS #36,809 · 7 patents
- Office Depot, Inc. #36,810 · 7 patents
- Officina Gourmet GmbH #36,811 · 7 patents
- Offset Ventures, LLC #36,812 · 7 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Ocuspecto's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Ocuspecto's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
19 5th percentile higher than 5% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 14.3% |
| 2016 | 1 | 14.3% |
| 2020 | 4 | 57.1% |
| 2021 | 1 | 14.3% |
Which technologies does Ocuspecto Oy patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Ocuspecto Oy's patent record in context - here's where to go next.
- Ocuspecto Oy's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 85.7% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #36,781 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Ocuspecto Oy against Oxti PTE Ltd, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 18.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.